editor note china intern import expo draw global corpor giant world trade leader upandcom star busi commerc expo launch fifth edit year china daili spoke senior execut multin corpor particip event five straight year present view cii role boost global econom recoveri covid19 q1 fifth straight year compani particip annual ciie event import expect year q2 ad signific ciie context downward pressur global economi brought covid19 pandem soften effect global demand q3 china strive increas import support manufactur produc economi countri also continu open market economi foreign investor foreign compani overal think china contribut world q4 compani oper specif industri prospect industri current china what biggest opportun compani countri pursu highqual develop q5 what view china current level openingup highstandard openingup made even effect futur leon wang execut vicepresid astrazeneca presid astrazeneca china a1 past five year astrazeneca evolv newcom regular ciie experienc strong spillov effect event particip allow us summar phase result china open new chapter cooper year ciie astrazeneca set one largest booth medic devic healthcar section demonstr growth essenti therapeut area introduc highqual innov product holist diseas manag solut a2 ciie year past year alway hear global choru place multin enterpris expand circl friend build ecosystem smaller enterpris also emb global valu chain new develop opportun ciie brought huge benefit enterpris whose growth key indic global econom recoveri ciie posit signal china give trade partner intern commun greater confid crucial time econom downturn a3 spillov effect ciie amplifi offer opportun foreign compani deepli explor chines market share develop dividend foreign exhibitor plant root china exhibit turn commod exhibitor turn investor multin pharmaceut compani astrazeneca one beneficiari china growth openingup respond call open cooper leverag increasingli enhanc busi environ china innov partner benefit patient china around world a4 believ china healthcar industri still stage fast growth boast great opportun though without challeng recent year chines govern public attach greater import health econom develop lot support polici clearer guidanc regul introduc highqual develop one prioriti set china healthcar industri respect astrazeneca see great opportun acceler innov cooper a5 past 40 year china success pursu promot develop reform openingup stage sustain longterm highspe econom growth confid chines market continu share china develop opportun expand oper countri work china drive world economi forward bian xin ceo roch pharmaceut china a1 past five year ciie becom import stage debut global innov product cuttingedg technolog also built excel platform commun exchang govern enterpris enterpris 20th nation congress communist parti china close believ open fifth ciie point fulli demonstr countri commit achiev highqual econom develop new stride reform openingup believ conven ciie provid chines opportun rest world roch encourag stronger confid commit chines market a2 great honor roch attend ciie five consecut year one largest booth area medic healthcar pavilion roch highlight full portfolio launch marketreadi product 1000squaremet booth includ nearli 10 global innov product soon launch china cover major diseas area hematolog tumor breast cancer ophthalmolog neurosci expo roch holist showcas multipl innov project solut hope leverag ciie bridg align chines govern partner enhanc exchang collabor seek synergi resourc foster industri develop jointli build creat share healthcar ecosystem china a3 recent year seen china deepen reform unleash market vital econom resili recent seri polici introduc help increas stabil improv qualiti foreign invest firmli believ posit measur boost confid continu deepen busi china increas busi china invest china a4 china becom world secondlargest pharmaceut market global compani like roch benefit countri openingup econom reform led favor busi environ easier market access healthcar sector seen signific improv polici measur acceler regulatori approv afford innov drug recent year promot transform upgrad industri highqual develop economi societi also hearten see govern place strateg prioriti ensur peopl health improv polici promot public health show govern commit elev health wellb chines peopl christin zhou senior vicepresid novo nordisk presid novo nordisk china a1 ciie repres opportun compani foster enhanc key partnership also offer uniqu commun platform help build public awar educ diabet well seriou chronic diseas past five year invest china four time deepen presenc across full valu chain showcas 18 innov medicin 10 inject devic expo hope leverag ciie enhanc public awar diseas improv health awar diseas manag skill look forward share latest innov rd focus across differ diseas area includ diabet obes hemophilia growth disord a2 despit uncertainti global economi impact covid19 fifth ciie held schedul serv window chines market ciie demonstr china commit expand promot inclus develop a3 chines economi maintain posit growth despit pandem impact believ china continu strong economi world provid sustain develop opportun across industri a4 chines govern elev peopl health nation develop strategi set ambiti goal forg comprehens full lifecycl healthcar system healthi china 2030 plan design concret measur prevent manag chronic diseas includ diabet obes chines healthcar reform continu deepen hope acceler innov achiev simultan clinic research china global patient china benefit innov medicin togeth countri region a5 past decad china made continu achiev openingup effort optim busi environ novo nordisk continu play activ role progress alongsid made contribut hope continu measur expand highlevel openingup optim busi environ chines market continu conduct busi activ financi social environment respons way novo nordisk aspir grow togeth china increas invest acceler innov dan brindl presid novarti group china a1 found ciie import platform showcas latest medicin innov acceler industri connect explor mutual benefici partnership great exampl everevolv partnership boao lecheng intern medic tourism pilot zone hainan provinc sign mou ciie 2020 anoth 2021 deepen collabor lecheng far weve introduc six drug pilot zone advanc nationwid approv amplif opportun partnership testimoni presenc ciie bear fruit a2 five year ciie becom premier intern trade fair attract wide rang particip variou nation industri sector enterpris given econom public health challeng around world think ciie take higher signific road global recoveri depend peopl nation come togeth time think expo import opportun remind world vibranc china shanghai welcom embrac chines peopl a3 can not exagger import china world global economi china continu journey reform openingup believ china import world stage continu evolv novarti china rank strateg market global china thirdlargest market believ becom secondlargest market 2024 a4 although china alreadi becom world secondlargest pharmaceut market still remain signific amount unmet medic need across countri certainli true mani therapeut area includ cardiovascular diseas immunolog neurosci oncolog ophthalmolog name time chines govern continu strengthen ecosystem support strong innov pharmaceut industri across valu chain includ china regulatori environ intellectu properti protect well medic insur benefit compani novarti a5 china focu reform openingup well attent inclus growth global economi strongli posit china world novarti deepli commit chines market proactiv govern polici help strengthen commit resolv chines market polici ecosystem continu evolv support busi innov china believ countri becom attract foreign investor novarti song global senior vicepresid johnson johnson chairman johnson johnson china a1 fifth consecut year johnson johnson particip ciie us grand expo provid uniqu opportun share cuttingedg innov world importantli join top mind healthcar industri stakehold paint pictur futur health human ride influenc past four cii mani johnson johnson innov product healthcar solut sped entri china meet grow health need chines patient consum look forward indepth engag partner platform a2 ciie import initi taken chines govern expand openingup winwin collabor support innov creat better intern busi environ despit challeng brought covid19 expo remain open busi around world continu facilit industri collabor commun ciie vivid testimoni resili china economi remain confid longterm prospect china market innovationdriven highqual develop china a3 37 year local oper wit openingup countri contribut well benefit extraordinari progress china grow becom world secondlargest economi hearten see countri drive develop trade partner play key role world strive recov a4 feel humbl work industri peopl health wellb first foremost prioriti past year wit continu rise peopl health awar time also encourag govern step effort healthcar reform incentiv innov improv access qualiti care remain posit longterm prospect china healthcar industri a5 sinc start reform openingup chines market undergon transform unseen part world throughout modern histori four decad without doubt open china brought enorm opportun busi around world usher new era continu encourag polici favor openingup governmentl initi support open fair busi environ well china effort bring innov healthcar product serv patient custom better faster way wayn shi head sanofi greater china a1 ciie import opportun mani multin compani includ sanofi share dividend china openingup develop play import role promot cooper increas confid build ecosystem innov prosper healthcar industri fifth ciie sanofi exhibit 23 strateg star innov product cover complex healthcar issu rare immun inflammatori diseas chronic diseas vaccin consum healthcar product includ five new product make debut china look forward contribut healthi china 2030 plan leverag global rd strength local insight import platform a2 backdrop continu covid19 situat ciie sent world messag open toler inclus mutual prosper also show resili amid multipl disrupt challeng expo spillov effect also bolster longterm confid multin enterpris continu develop china sanofi look forward leverag ciie platform spillov effect bring faster better innov medic solut chines patient a3 china world secondlargest economi also major contributor global econom growth high level openingup adher given strong impetu develop world economi china alway center global strategi look ahead equal upbeat china seiz innov insight healthcar sector develop enthusiast explor new treatment patient a4 china econom pattern evolv one featur quantitydriven growth highqual develop innov hold key critic transform sanofi share sentiment fuel busi sanofi continu innov improv peopl live consist acceler introduct innov medicin vaccin enhanc access innov medicin focus digit innov enhanc effici a5 recent year felt china determin confid encourag innov deepli creat intern firstclass busi environ promot new model highlevel openingup china activ support foreign invest environ provid opportun foreign pharmaceut compani better develop china honor wit beneficiari china reform openingup polici